Technical Briefing: Celsion Corp., Theravance Inc., Alkermes PLC, and Hospira
LONDON, October 1, 2013
LONDON, October 1, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
The U.S. equity market posted losses on Monday, September 30, 2013, with the
S&P 500, the Dow Jones Industrial Average, and the NASDAQ Composite falling by
0.60%, 0.84%, and 0.27%, respectively. Shares in the healthcare sector mostly
ended on a lower note as the broader market declined. The major movers in the
sector included Celsion Corporation (NASDAQ: CLSN), Theravance Inc. (NASDAQ:
THRX), Alkermes PLC (NASDAQ: ALKS), and Hospira Inc. (NYSE: HSP). All these
companies are tracked by AAAResearchReports.com. Free technical research
reports on CLSN, THRX, ALKS, and HSP can be accessed by signing up at:
Celsion Corp.'s stock fell sharply by 1.71% on Monday, tracking losses in the
broader market. The company's shares vacillated between $1.15 and $1.19 before
finishing the day at $1.15. A total of 0.85 million shares were traded, which
is below the daily average volume of 2.03 million. Despite Monday's pullback,
Celsion Corp.'s shares have gained 12.75% in the previous three months,
outperforming the S&P 500 which has gained 4.69% during the same period.
Furthermore, the company's stock is trading below its 50-day and 200-day
moving averages of $1.21 and $2.30, respectively. Download free report on CLSN
upon registration at:
Shares in Theravance Inc. fell sharply on Monday to close at$40.87, which is
1.18% lower than the previous day's closing price of$41.36. The company's
shares oscillated between $40.50 and $41.27 during the trading session. A
total of 0.81 million shares were traded, which is below the daily average
volume of 0.88 million. The company's shares have gained 14.00% in the last
one month and 6.07% in the previous three months, compared to a gain of 2.97%
and 4.69% in the S&P 500 during the respective periods. Additionally,
Theravance Inc.'s stock is trading above its 50-day and 200-day moving
averages of $38.16 and $30.85, respectively. THRX technical report can be
accessed for free by signing up at:
Alkermes PLC's stock ended slightly lower on Monday as the broader market
finished on a negative note. The company's shares fluctuated between $33.01
and $33.80 before ending the day 0.06% lower at $33.62. A total of 0.83
million shares were traded, which is below the daily average volume of 1.14
million. The company's shares have gained 5.89% in the last one month and
17.22% in the previous three months, outperforming the S&P 500 which has
advanced 2.97% and 4.69% during the respective periods. Moreover, Alkermes
PLC's stock is trading above its 50-day and 200-day moving averages of $33.24
and $27.39, respectively. A free report on ALKS can be accessed by registering
Hospira Inc.'s stock rose 0.82% on Monday, reversing all of the losses from
the previous trading session. The company's shares closed the day at $39.22
after oscillating between $38.45 and $39.26. A total of 0.67 million shares
were traded, which is below the daily average volume of 0.86 million. The
company's shares have gained 0.18% in the previous three trading sessions,
compared to a loss of 0.66% in the S&P 500 during the same period. Further,
Hospira Inc.'s stock is trading above its 200-day moving average of $35.17.
Register with AAA Research Reports and download research on HSP for free at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
only human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
SOURCE AAA Research Reports
Contact: Peter F. Jones, + 1 (646) 396-9126, email@example.com
Press spacebar to pause and continue. Press esc to stop.